How much are atypical antipsychotic agents being used, and do they reach the populations who need them? A Canadian experience

This publication has 24 references indexed in Scilit:

• Lessons learned from trends in psychotropic drug expenditures in a canadian province.
  Psychiatric Services, 2001
• Recommendations for the Management of Behavioral and Psychological Symptoms of Dementia
  Canadian Journal of Neurological Sciences, 2001
• Using forecasting models to estimate the effects of changes in the composition of claims for selective serotonin reuptake inhibitors on expenditures
  Clinical Therapeutics, 2001
• Atypical antipsychotics: are some more atypical than others?
  Psychopharmacology, 2000
• Pharmacologic treatment of schizophrenia
  Biological Psychiatry, 1999
• Incidence and Predictors of Drug-Induced Parkinsonism in Older Psychiatric Patients Treated With Very Low Doses of Neuroleptics
  Journal of Clinical Psychopharmacology, 1999
• The Economic Burden of Schizophrenia in Canada
  The Canadian Journal of Psychiatry, 1999
• Tardive dyskinesia and atypical antipsychotic drugs
  Schizophrenia Research, 1999
• New Atypical Antipsychotics
  Drugs & Aging, 1998
• One-Month Prevalence of Mental Disorders in the United States
  Archives of General Psychiatry, 1988